ID
19760
Descripción
The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS. Documentation process: This form is to be obtained in Screening.
Palabras clave
Versiones (1)
- 27/1/17 27/1/17 -
Subido en
27 de enero de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
- StudyEvent: ODM
Descripción
If 'Yes' record each detail below. If a category has multiple details, record each on a separate line. Mark if resolved or current.
Descripción
Line
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0750480
Descripción
Category Number
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0683312
Descripción
resolved or current
Tipo de datos
integer
Descripción
details
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1522508
Similar models
Medical History CRFs Multiple Sclerosis Tysabri NCT00027300
- StudyEvent: ODM